The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.
about
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementExhaustive Fluorine Scanning toward Potent p53-Mdm2 AntagonistsEndocarditis due to high-level gentamicin-resistant Enterococcus faecalisIdentification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcusInfluence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.Vancomycin-resistant Enterococcus faecium colonization in childrenVancomycin-resistant enterococci.Antimicrobial resistance in Canada.Lactic acid bacteria and human clinical infection.Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase.DNA persistence and relapses questions on the treatment strategies of Enterococcus infections of prosthetic valves.Hospital-acquired infections: diseases with increasingly limited therapies.In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.Overexpression and characterization of the chromosomal aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium.In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptideIn vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium.Versatility of aminoglycosides and prospects for their future.Current perspectives on glycopeptide resistance.Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled studyCombining quinupristin/dalfopristin with other agents for resistant infections.Novel aminoglycoside 2''-phosphotransferase identified in a gram-negative pathogen.The new threats of Gram positive pathogens: re-emergence of things past.Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.Engineering challenges in biodiesel production from microalgae.Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.Colonial variation in vancomycin resistant Enterococcus faeciumPheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication.Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147.Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway.Multiple-antibiotic resistance of Enterococcus spp. isolated from commercial poultry production environments.Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom.Enterococcus faecalis mammalian virulence-related factors exhibit potent pathogenicity in the Arabidopsis thaliana plant model.Resistance to antibiotics used in dermatological practice.Recent advances: antiinfectives.Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid.In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis.Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
P2860
Q26798630-FE1FE0E7-2CC6-4F6A-AA98-AE78353D4C6AQ27674554-A2F2FDEC-63DE-4C81-BA6A-18157AEC9358Q28368076-9C7740F7-B0B1-4AFC-8E6D-862937439C0DQ30649783-04B0ED5B-E36B-428F-93A0-167A06B6520EQ33745963-372FBD4E-0136-48F7-BED7-14D1C33B8AC1Q33958749-EFB72FC0-F201-409D-BCA3-F6C2557412C8Q33975592-B8F35546-1EE5-41CD-9819-635BD687F199Q34133853-F1981584-FA6C-4DA8-BDDB-99B4206A9A18Q34358055-5FC6B6DB-74BF-4986-BB75-D36CE7D2E9FAQ34438814-6058EA8C-AA74-4CE8-ACC8-AEA1CE3854F9Q34541859-B8A4451B-0CB8-434B-B0BD-D76F99A285D0Q35113057-7C4AEF96-5B2D-4669-BD75-7434FB948A45Q35118711-87BA2BFA-B1AF-4C7F-93D1-DF82F9BCB5D8Q35135819-83DB8354-445E-499B-A75A-D9E6524E8186Q35138478-759C2122-EAA5-46AB-88E4-A0F08E117BEEQ35139128-A7F4EFB3-75E8-4A18-BDD1-AC68D8C9A6EFQ35176271-EA5BC602-02A0-483A-A7AD-2969C53A636BQ35368590-1FA9DFE2-0C13-4485-ABEA-47F210E17A38Q35505427-DAA9DB09-9A98-4DBC-A1F4-3861987F54DFQ35678253-AAC9B7EF-EAA6-4F18-8DBD-8279D94EDC08Q36505481-CC65B5F2-1AB4-4FA1-A8D8-4CE73DA7819EQ37218104-C0314B18-CEA0-43C3-851E-DDE25D93D65AQ37392879-63A19158-C417-4501-8608-9EBF3BDD9F65Q38026911-6ABBE9B4-A23C-432B-A8B6-0BDFB067BE7BQ39472007-CA79B891-BB9E-4194-9C0E-C9CF8FEECDCFQ39613351-963B4B49-DBB7-48DE-B599-FD631D7189BFQ39835619-2153AAD5-6912-460B-B7A1-01A19462B226Q39879697-16CDD9BF-14D8-4967-9EF9-119A36F49E3BQ39950603-0E023BDD-D1A7-40A6-8DCC-837AA3795CEBQ40171996-839F1EE5-34FA-490E-BAD8-A0788333BE19Q40187074-1C8B6C98-0B24-4387-BBC6-2E1C6D17AA5DQ40734908-EAA70B5F-CE18-437F-B5A4-0BBFAE6B2F30Q40824186-167202CB-F706-4BC2-AD50-D7A3821A4FBBQ41142612-C508E23D-F87E-4F51-A46F-C98C01CBC26CQ43773396-6A27F128-5DA3-4688-88FC-8E1C853B4E6CQ44717183-8E3BA7EB-B8BD-45FF-AD9E-BC85B5D53D8EQ44999822-CA11B8BA-1D0B-4ACD-9C43-3E66CBA46227Q45915910-D9B4808D-9F4C-4C26-9592-AC0648A2D3DEQ45972605-DC539F00-9050-4AB0-B0AA-6AD37FCB5E58Q54090771-6F2F1203-F5BE-41FB-BE9C-D9815268C446
P2860
The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
The Garrod Lecture. The entero ...... stance on therapeutic options.
@en
The Garrod Lecture. The entero ...... stance on therapeutic options.
@nl
type
label
The Garrod Lecture. The entero ...... stance on therapeutic options.
@en
The Garrod Lecture. The entero ...... stance on therapeutic options.
@nl
prefLabel
The Garrod Lecture. The entero ...... stance on therapeutic options.
@en
The Garrod Lecture. The entero ...... stance on therapeutic options.
@nl
P356
P1476
The Garrod Lecture. The entero ...... stance on therapeutic options.
@en
P2093
Moellering RC Jr
P356
10.1093/JAC/28.1.1
P407
P577
1991-07-01T00:00:00Z